Suppr超能文献

活化因子 XII 的纤溶特性

Fibrinolytic properties of activated FXII.

作者信息

Braat E A, Dooijewaard G, Rijken D C

机构信息

Gaubius Laboratory, TNO-PG, Leiden, The Netherlands.

出版信息

Eur J Biochem. 1999 Aug;263(3):904-11. doi: 10.1046/j.1432-1327.1999.00593.x.

Abstract

Activated factor XII (FXIIa), the initiator of the contact activation system, has been shown to activate plasminogen in a purified system. However, the quantitative role of FXIIa as a plasminogen activator in contact activation-dependent fibrinolysis in plasma is still unclear. In this study, the plasminogen activator (PA) activity of FXIIa was examined both in a purified system and in a dextran sulfate euglobulin fraction of plasma by measuring fibrinolysis in a fibrin microtiter plate assay. FXIIa was found to have low PA activity in a purified system. Dextran sulfate potentiated the PA activity of FXIIa about sixfold, but had no effect on the PA activity of smaller fragments of FXIIa, missing the binding domain for negatively charged surfaces. The addition of small amounts of factor XII (FXII) to FXII-deficient plasma induced a large increase in contact activation-dependent PA activity, as measured in a dextran sulfate euglobulin fraction, which may be ascribed to FXII-dependent activation of plasminogen activators like prekallikrein. When more FXII was added, PA activity continued to increase but to a lesser extent. In normal plasma, the addition of FXII also resulted in an increase of contact activation-dependent PA activity. These findings suggested a significant contribution of FXIIa as a direct plasminogen activator. Indeed, at least 20% of contact activation-dependent PA activity could be extracted from a dextran sulfate euglobulin fraction prepared from normal plasma by immunodepletion of FXIIa and therefore be ascribed to direct PA activity of FXIIa. PA activity of endogenous FXIIa immunoadsorped from plasma could only be detected in the presence of dextran sulfate. From these results it is concluded that FXIIa can contribute significantly to fibrinolysis as a plasminogen activator in the presence of a potentiating surface.

摘要

活化因子 XII(FXIIa)是接触激活系统的启动因子,已证实在纯化系统中可激活纤溶酶原。然而,在血浆中接触激活依赖性纤维蛋白溶解过程中,FXIIa 作为纤溶酶原激活剂的定量作用仍不清楚。在本研究中,通过在纤维蛋白微量滴定板试验中测量纤维蛋白溶解,检测了 FXIIa 在纯化系统和血浆硫酸葡聚糖优球蛋白组分中的纤溶酶原激活剂(PA)活性。发现 FXIIa 在纯化系统中具有较低的 PA 活性。硫酸葡聚糖使 FXIIa 的 PA 活性增强约六倍,但对缺少带负电荷表面结合域的 FXIIa 较小片段的 PA 活性没有影响。向 FXII 缺陷血浆中添加少量因子 XII(FXII)会导致接触激活依赖性 PA 活性大幅增加,如在硫酸葡聚糖优球蛋白组分中所测,这可能归因于 FXII 依赖性激活诸如前激肽释放酶等纤溶酶原激活剂。当添加更多 FXII 时,PA 活性持续增加,但增幅较小。在正常血浆中,添加 FXII 也导致接触激活依赖性 PA 活性增加。这些发现提示 FXIIa 作为直接纤溶酶原激活剂有显著作用。实际上,通过免疫去除 FXIIa 从正常血浆制备的硫酸葡聚糖优球蛋白组分中可提取出至少 20%的接触激活依赖性 PA 活性,因此可归因于 FXIIa 的直接 PA 活性。仅在存在硫酸葡聚糖的情况下才能检测到从血浆中免疫吸附的内源性 FXIIa 的 PA 活性。从这些结果得出结论,在存在增强表面的情况下,FXIIa 作为纤溶酶原激活剂可对纤维蛋白溶解有显著贡献。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验